Follow today’s news live. What we learned, 22 September 2024 06:56 With that we’re wrapping up the blog. Before ...

DelveInsight’s, “Head and Neck Cancer Pipeline Insight 2024” report provides comprehensive insights about 80+ companies and ...

Soriot, who weathered storms in Europe over Covid-19 contracts, faces a very different and more mercurial government in Beijing. GSK, and countless people hanging on to to democracy and free ...

The World Health Organization said on Friday it had cleared Bavarian Nordic's mpox vaccine, the first such shot to be ...

Circle Pharma, Inc., a clinical-stage biopharmaceutical company dedicated to discovering and developing cell-permeable macrocycles as a new class of therapies, today announced two executive ...

The BTK inhibitors market has experienced significant dynamics driven by advancements in oncology and autoimmune disease ...

Beijing biotech Sironax has closed a whopping $200 million second-round financing that shows investors still have a desire to back companies working on RIPK1 inhibitors despite setbacks for GSK in ...

In the FTSE 100, GSK was up 0.8%. The pharmaceutical firm ... Sullivan arrived in Beijing on Tuesday, the first US national security advisor to visit China since 2016, for three days of talks ...

"There will be more innovative and cost-effective solutions from GSK for both the treatment and prevention of ... a manageable chronic infectious one," said Dai Lili, a professor at Beijing Youan ...